This review summarizes the major changes and stepwise approach in the 2017 ACC/AHA hypertension guidelines.
Answers are grounded in this paper and cite their sources.
May aid clinician reference to 2017 ACC/AHA hypertension guidelines; leaves open need for updated syntheses amid newer evidence.
Hypertension (HTN) is a widely prevalent disease across the globe. Recent reports from National Health and Nutrition Examination Surveys (NHANES) indicate that the prevalence of HTN is 29% in adults more than 18 years in the US This is about 72 million adults. Worldwide, about 1.3 billion people are affected by HTN [2]. This number is projected to increase several-fold in the coming years. Given the huge burden of this disease to the healthcare system and the many deleterious effects that can result from uncontrolled HTN, we need strong guidelines to manage the same. The recently published 2017 ACC/AHA guidelines [3] on hypertension management are very meticulous and include a comprehensive stepwise approach in treating hypertension. Here we present a summary of the major changes and a concise review of the new guidelines.
No takes yet. Share an insight, caveat, or question.
Swethika Sundaravel (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: